MELCHOR GOCHIOCO: Open Payments
NPI 1386654788 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,429 in 50 payments from 12 companies in 2025. Trend: 2023 $2,383 · 2024 $1,545 · 2025 $2,429
Food & beverage: $2,429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $432 |
| Intra-Sana Laboratories | 9 | $386 |
| Amgen Inc. | 10 | $381 |
| Novo Nordisk Inc | 6 | $265 |
| Abbott Laboratories | 1 | $215 |
| Lilly USA, LLC | 7 | $177 |
| Dexcom, Inc. | 4 | $153 |
| Daiichi Sankyo Inc. | 1 | $150 |
| Astellas Pharma US Inc | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $112 |
Products named: RELTONE 200 MG, AIRSUPRA, Otezla, FREESTYLE LIBRE 3, BREZTRI, INJECTAFER, DEXCOM G7 GSS (161), Ozempic.
Industry payments across NV — which companies pay providers there.
